P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY
N. Shah,
D. Ayers,
S. Cope,
K. Karampampa,
K. Towle,
J. Braverman,
A. Mojebi,
C. Caisip,
D. Dhanda
Affiliations
N. Shah
1 University of California San Francisco, San Francisco, CA, United States of America
D. Ayers
2 PRECISIONheor, Vancouver, BC, Canada
S. Cope
2 PRECISIONheor, Vancouver, BC, Canada
K. Karampampa
3 Bristol Myers Squibb, Princeton, NJ, United States of America
K. Towle
2 PRECISIONheor, Vancouver, BC, Canada
J. Braverman
3 Bristol Myers Squibb, Princeton, NJ, United States of America
A. Mojebi
2 PRECISIONheor, Vancouver, BC, Canada
C. Caisip
2 PRECISIONheor, Vancouver, BC, Canada
D. Dhanda
3 Bristol Myers Squibb, Princeton, NJ, United States of America
